COSCIENS ACQUIRES NUALTIS CORP.
TORONTO, ONTARIO, Sept. 10, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) is pleased to announce the acquisition of Nualtis Corp. (“Nualtis”), a Montreal-based specialty pharmaceutical technology business focused primarily on proprietary oral thin-film drug delivery technologies, with applications for both human and animal health. The Company also […]
Financial Post
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Financial Post.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
Financial PostTier B
COSCIENS ACQUIRES NUALTIS CORP.(opens original report in a new tab)
How CurrentWire compiled this story
Financial Post (financialpost.com), a Tier B publisher, filed this report on . CurrentWire published this page 8 minutes later, on .
Signal breakdown
CurrentWire ranked this story 58.7 of 100 in the snapshot this page was rendered from.
- Freshness
- 32.2 of 35
- Source authority
- 7 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 10 of 10
- Story prominence
- 5.5 of 10
- Velocity
- 0 of 5
Strongest signal: geographic relevance, 10 of 10. How each signal is calculated.
Filed under Business · Canada · Press release. Topics extracted from this report, with other live CurrentWire stories mentioning each: Toronto (6), Montreal (1), Ontario (4), ACQUIRES NUALTIS CORP (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.